MedDeviceGuideMedDeviceGuide
Back

European Union Medical Device Registration Cost 2026: EC REP Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How much does it cost to register a medical device in the European Union in 2026? A buyer-side breakdown of EU Authorized Representative (EC REP) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for MDR and IVDR portfolios.

Ran Chen
Ran Chen
Global MedTech Expert | 10× MedTech Global Access
2026-04-2440 min read

How Much Does It Cost to Register a Medical Device in the European Union in 2026?

For a single foreign-manufactured device entering the EU in 2026, expect a 3-year EU Authorized Representative (EC REP) service budget of roughly USD 6,000–18,000 for a single-device-group MDR or IVDR mandate and USD 12,000–60,000 for a multi-device-group portfolio, excluding Notified Body fees, EUDAMED implementation costs, and Common Specifications testing. EUDAMED registration is free; Notified Body fees are independently published. The 3x spread is driven almost entirely by how your EC REP bills you for the recurring Article 11 mandate.

Three pricing models dominate the EU AR market today, with a 5x spread for the same scope:

EC REP Pricing Model Year 1 (1 group) Year 1 (3 groups) 3-Year Total (1 group) 3-Year Total (3 groups)
Hourly billing $5,000–$11,000 $12,000–$25,000 $11,000–$22,000 $25,000–$55,000
Setup fee + lower annual $3,500–$8,000 $7,000–$15,000 $8,000–$18,000 $18,000–$40,000
Flat all-inclusive annual fee $2,000 $3,000 $6,000 $9,000

The EU AR mandate is not one-time — it is a recurring legal relationship for as long as your device is on the EU market. For background on what the EC REP role requires, see EU Authorized Representative (EC REP): Complete Guide. This guide focuses on procurement of EC REP services — pricing models, scope traps, contract terms, switching mechanics — not on Article 11 obligations.

Skip to Your Scenario

Why EC REP Pricing Is Where EU Budgets Win or Lose

MDR Article 11 (Regulation (EU) 2017/745) and IVDR Article 11 (Regulation (EU) 2017/746) require every manufacturer not established in the EU to designate a single EU Authorized Representative as a precondition of placing devices on the EU/EEA market. The EC REP signs the written mandate, holds a copy of the technical documentation, registers as an economic operator in EUDAMED, obtains an SRN, provides the Competent Authority contact point across all 27 Member States, forwards incident notifications, and can be held jointly and severally liable with the manufacturer under Article 11(5).

The EC REP is not optional and not one-time. The mandate runs for the lifetime of the device on the EU market — through 5-year CE certificate cycles, plus the IVDR transitional deadlines under Regulation (EU) 2024/1860 (Class D high-individual-risk through December 2027, Class C through December 2028, Class B and Class A sterile through December 2029). Small differences in pricing model compound enormously over a multi-decade product life.

The buyer has real negotiating leverage here because:

  • Article 11 scope is exhaustively defined in regulation — the mandate is standardized.
  • 60+ firms compete in the EU AR market across Belgium, Ireland, Germany, the Netherlands, France, and Italy.
  • Switching is procedurally codified in MDR/IVDR Article 12 (Change of Authorized Representative).
  • EUDAMED economic-operator registration is free.

The catch: most EU AR pricing is not published. Buyers run RFPs and compare proposals where every firm has a different scope inclusion list — particularly on technical documentation review depth, EUDAMED data entry, vigilance triage, Free Sale Certificate handling, and the PRRC interface. That is exactly the comparison this article is designed to short-circuit.

The Three EC REP Pricing Models, Decoded

Model 1: Hourly billing ("charge by hour")

The default model for EU regulatory boutiques in Germany, Belgium, and Ireland. Scope is captured in a Statement of Work; everything outside scope (EUDAMED uploads beyond an initial allotment, additional FSC requests, Competent Authority correspondence beyond a quarterly cap) is billed at hourly rates of $140–$425/hour:

Consultant Tier EU Hourly Rate (2026) Typical Work
Tier 1 — senior MDR/IVDR strategist, PRRC $350–$425/hr Article 11 disputes, Competent Authority escalations, Notified Body strategy, recall coordination
Tier 2 — regulatory specialist $260–$315/hr Technical documentation review, EUDAMED data entry, mandate drafting, vigilance triage
Tier 3 — associate / regulatory analyst $140–$185/hr Translation coordination, label review, FSC requests, SRN administration

(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region.)

Why buyers choose hourly: flexibility, perceived control, ability to use the EC REP only when needed.

Why hourly is bad for buyers in practice:

  • No incentive to be efficient. Every hour the EC REP spends is revenue.
  • Surprise invoices. Article 11(3)(a) document review becomes 8–16 hours per device family. The bill arrives 30–60 days later.
  • Scope creep is invisible until it bills. An IFU update following an MDCG guidance refresh can be 2 hours or 12.
  • Disincentive to communicate. Every email, every PRRC clarification call is potentially billable.
  • Year 1 cash flow shock. Mandate drafting, EUDAMED Actor registration, document review, and initial UDI/Device Module submissions are front-loaded — typically 3–4x steady-state annual hours.

A typical Class IIb hourly engagement for a single Basic UDI-DI runs $8,000–$15,000 in Year 1 and $3,000–$8,000/year thereafter.

Model 2: Setup fee + lower annual maintenance

The dominant model for mid-to-large EU AR firms (Obelis, MedPass International, Donawa, Emergo by UL, Casus Consulting, Freyr, Veranex, MedNet, MedEnvoy). One-time setup plus smaller recurring annual fee. Each "extra" is an itemized add-on.

Typical industry composite:

Component MDR Class I MDR Class IIa/IIb MDR Class III / IVDR Class C-D
One-time setup fee (mandate drafting, KYC) $400–$1,200 $500–$1,500 $1,000–$3,000
EUDAMED Actor registration / SRN activation $300–$700 $300–$700 $300–$700
Annual EC REP fee $1,200–$2,800 $1,500–$3,800 $2,200–$5,000+
Per-additional-device-registration fee $100–$300 $100–$300 $100–$300
Mandate amendment $150–$400 $150–$400 $150–$400
Free Sale Certificate (FSC) issuance $200–$2,200 $200–$2,200 $200–$2,200
Document review (Class I / self-cert IVD) per-device sometimes included sometimes included
Vigilance event handling hourly above scope hourly above scope hourly above scope

The trap: "low annual fee starting at €1,200" turns into $2,500–$6,000 in Year 1 once setup + EUDAMED + per-device + FSC fire together. Add an MDR amendment and a $1,200 headline becomes a $4,000 first-year invoice.

Where this model fails buyers:

  • Year 1 cash flow shock is structural. Major one-time fees fire before the CE certificate exists.
  • EUDAMED data entry is unbounded. Each Basic UDI-DI carries ~60 mandatory data fields under MDR Annex VI Part B; some firms treat each labeling change as a fresh billable.
  • FSC requests scale with export markets. A manufacturer using its EU CE mark for Brazil, Saudi Arabia, MENA, ASEAN, and LatAm may need 5–15 FSCs/year. At $200–$2,200 each, that is $1,000–$30,000/year of invisible tax.
  • Article 11(3)(a) review depth is poorly defined. "Verify" means anything from a 30-minute checklist to a 40-hour audit depending on provider.

Model 3: Flat all-inclusive annual fee

A newer model where the EC REP charges a single annual fee per device group covering the Article 11 mandate, EUDAMED Actor registration, SRN administration, FSC requests, Article 11(3)(a) document review, vigilance forwarding, and Competent Authority correspondence — the same number every year.

Two structural advantages:

  1. Flat curve. Year 1 = Year 2 = Year 3. The pre-CE-certificate period is no longer cash-flow-hostile.
  2. Incentives align. Once signed, every additional hour the EC REP spends is pure cost to them — they are motivated to file cleanly and avoid Competent Authority queries.

The catch: flat-fee EC REPs typically require a multi-year contract and exclude separately quoted MDR/IVDR consulting (gap analysis, CER/PER writing, technical documentation compilation).

As of April 2026, Pure Global is the only major EU AR provider that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing) — the only published reference point for buyers comparing models.

Why this guide uses Pure Global as the worked example

Pure Global's published EC REP rates are used throughout this article because they are the only flat-fee EU AR rates in the public domain — anyone can verify them at pureglobal.com/services/pricing. This is not an endorsement. The published rates simply let us do an apples-to-apples comparison that would otherwise require RFPs to multiple firms under NDA. Industry ranges for hourly and setup-plus-annual models are based on typical RFP responses observed across Obelis, MedPass International, Donawa, Emergo, Casus Consulting, Freyr, MedNet, MedEnvoy, and Veranex.

Recommended Reading
Switzerland Medical Device Registration Cost 2026: CH-REP Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
Regulatory EU MDR / IVDR2026-04-24 · 42 min read

How EU Device Grouping Works (and Why It Drives EC REP Pricing)

Pure Global prices the EC REP mandate per device group, not per SKU or per UDI-DI. Under MDR/IVDR Annex VI Part C, every device or family of variants belonging to the same generic device group gets a Basic UDI-DI — the master regulatory grouping identifier issued by GS1, HIBCC, ICCBBA, or IFA. The Basic UDI-DI groups devices with the same intended purpose, risk class, and essential design characteristics. A single Basic UDI-DI can contain dozens or hundreds of individual UDI-DIs (SKU-level identifiers).

Grouping Identifier What It Identifies EC REP Pricing Implication
Basic UDI-DI Device family / device group Pure Global tier counter
UDI-DI Specific SKU / configuration Generally not billed separately
UDI-PI Production identifier (lot, serial) Manufacturer responsibility, not EC REP scope

A Class IIb infusion pump family with 12 SKUs sharing one Basic UDI-DI is one device group. An IVD reagent line of 25 SKUs sharing a single Basic UDI-DI is one device group. This is structurally different from competitors who quote per UDI-DI or per individual device registration — a manufacturer with 200 SKUs across 4 Basic UDI-DIs pays the 4-group tier, not the 200-device tier.

Pure Global EU EC REP Pricing (Published, April 2026)

EC REP Mandate — Per Device Group, MD and IVD All Classes

Number of Device Groups Annual Flat Fee (USD)
1 $2,000
2 $2,500
3 $3,000
4 $3,500
5 $4,000
6+ Custom quote

Included in the annual fee — per Pure Global's published price list ("document review, free sale certificate requests, EUDAMED support"):

  • Article 11(3)(a) document review — verifying that the EU Declaration of Conformity, technical documentation, and (where applicable) NB certificate are drawn up. Routine review is included; deep Notified Body TDA review support is separately quoted at $200/hour (see consulting menu)
  • Free Sale Certificate (FSC) request handling with the EC REP's home Competent Authority — Pure Global submits the application and manages correspondence; the Member State authority's per-FSC fee (€50–€600) is passed through at cost
  • EUDAMED support — routine — Actor Module registration, SRN issuance, actor data maintenance, and standard UDI/Device Module submissions for contracted device groups. Project-level intensive EUDAMED work (initial bulk Device-module population for very large portfolios, complex actor migrations, or backfilling legacy device data) is separately quoted at $200/hour under "EUDAMED Support" on the consulting menu

Inherent to the EC REP statutory role under MDR/IVDR Article 11 (included by definition, not separately billable):

  • Holding the Article 11 written mandate; EC REP/EU REP symbol authorization for labeling under ISO 15223-1
  • Receiving and forwarding Competent Authority correspondence under Article 11(3)(d)–(f) (Article 11(3)(b) sample requests, Article 11(3)(c) compliance information requests)
  • Forwarding vigilance reports (incident reports, FSCAs) under Article 11(3)(g) — the EC REP routes notifications between manufacturer and the relevant Competent Authority; preparing the manufacturer's incident analysis is not in scope
  • Maintaining permanent and continuous access to a PRRC within the EC REP organization under Article 15(6) — note this is the EC REP's own PRRC (a regulatory requirement on the EC REP firm itself); it is not Pure Global providing PRRC services to the manufacturer's QMS, which is a separate Article 15 obligation on the manufacturer

Not included — separately quoted on Pure Global's published consulting menu (see next section for line-item rates): MDR/IVDR classification, regulatory pathway, gap analysis, CER/PER compilation/writing, technical documentation compilation, training, QMS support, NB TDA review beyond Article 11(3)(a), RAQA/EUDAMED ad-hoc support, NB audit attendance, certified IFU translations, Article 13/14 importer/distributor functions.

Government / NB / Member State pass-through (no markup): EUDAMED registration is free. Notified Body fees (application, TDA, surveillance) are paid directly to the NB. Member State FSC fees (€50–€600) are passed through at cost via the EC REP.

Tier dynamics — what counts as "an amendment" vs "a new device group": Adding a new SKU/UDI-DI within an already-contracted Basic UDI-DI is an included mandate amendment. Adding a new Basic UDI-DI moves you into the next pricing tier (e.g., 1 group → 2 groups = +$500/year). Reclassification within the same group (e.g., under Common Specifications) is included.

Contract Terms

  • Standard contract: 3 years.
  • Annual contract option: available, but the first-year fee is increased by 50%.
  • Early termination: allowed at any time with a 50% payoff of the remaining contract value.
  • Ad-hoc consulting (out-of-scope work): $200/hour for RAQA support, EUDAMED support, Notified Body TDA review support; with a "China-based experts" alternative at 50% off the listed fee for the consulting menu.

(Source: pureglobal.com/services/pricing, captured April 2026. EU pricing schedule version 1.1, last updated 2026-01-12.)

Optional MDR/IVDR Consulting Menu (Separate from EC REP)

Pure Global publishes a separate consulting menu for non-AR work that some manufacturers buy alongside the EC REP mandate. These are not bundled into the flat EC REP fee.

Consulting Service Listed Fee (USD)
MDR/IVDR Training $2,000/day
Classification Assessment (MDR or IVDR) $2,000/device family
Regulatory Pathway (MDR or IVDR) $5,000/device family
Gap Analysis (MDR or IVDR) $5,000/device family
CER Compilation only (Class I) → (Class IIb/III) $10,000–$22,000
CER Compilation and Writing (Class I) → (Class IIb/III) $15,000–$30,000
Technical Documentation Compilation MDR $8,000–$15,000
PER Compilation only (IVDR Class A) → (Class C/D) $10,000–$22,000
PER Compilation and Writing (IVDR Class A) → (Class C/D) $15,000–$30,000
Technical Documentation Compilation IVDR $8,000–$15,000
Notified Body TDA Review Support $200/hour
QMS support EU MDR/IVDR (8 hr impl + 4×2h training) $3,500
RAQA / EUDAMED Ad hoc support $200/hour

A unique feature: when a manufacturer accepts the China-based experts delivery model, the listed consulting fee is reduced by 50% (e.g., Class IIb CER Compilation drops from $22,000 to $11,000). The model uses MDR/IVDR-trained engineers in mainland China supervised by EU-based PRRCs and senior consultants. The Article 11 EC REP mandate, the SRN, and the PRRC remain EU-resident regardless. No other major EU AR provider publishes a comparable offshore-experts discount.

For deeper context on what these consulting deliverables contain, see EU MDR and IVDR: The Complete Guide and How Much Does CE Marking Cost for Medical Devices?.

3-Year Cash Flow: Side-by-Side Comparison

The pricing model only matters because of cash timing. The following scenarios show the same scope of work — EC REP mandate only, government-fee-equivalents excluded, Notified Body fees excluded — under each of the three models. Numbers are illustrative and based on the ranges given above.

Scenario A: Single Device Group, 3-Year Total

One Basic UDI-DI (e.g., MDR Class IIa wound-care family with 6 SKUs), first-time EC REP appointment.

Cost Bucket Hourly Billing Setup + Annual Flat Fee (Pure Global)
Year 1 mandate + EUDAMED Actor + SRN $4,500 $2,500 $2,000
Year 1 Article 11(3)(a) doc review $2,200 included included
Year 1 EUDAMED UDI/Device submissions $1,300 $400–$800 included
Year 1 1 FSC + 1 amendment $1,200 $700 included
Year 1 total $9,200 $3,900–$4,500 $2,000
Year 2 maintenance $3,400 $2,000 + $700 add-ons $2,000
Year 3 maintenance $3,400 $2,700 $2,000
3-Year Total $16,000 $9,300–$9,900 $6,000
Year 1 share of 3-year spend 58% 45% 33%

Year 1 burden under flat fee is $2,000 vs $9,200 under hourly for the same regulatory output. The $7,200 of cash that does not leave the company in Year 1 is often the difference between launching in the EU this fiscal year and deferring 12 months.

Scenario B: Single Class IIb MDR Device with Active PMCF, 3-Year Total

One Basic UDI-DI for a Class IIb electromedical device, post-CE-mark, with active PMCF updates and periodic IFU revisions per MDR Annex XIV Part B.

Cost Bucket Hourly Billing Setup + Annual Flat Fee (Pure Global)
Year 1 mandate + EUDAMED Actor + SRN $5,500 $3,500 $2,000
Year 1 Article 11(3)(a) doc review (Class IIb) $3,800 $1,200 included
Year 1 EUDAMED + SSCP + cert linkage $2,500 $1,000 included
Year 1 PMCF-driven IFU amendments (2) $1,500 $800 included
Year 1 vigilance triage (3 events) $1,200 $600 included
Year 1 2 FSCs (Saudi + Brazil) $1,500 $1,000 included
Year 1 total $16,000 $8,100 $2,000
Year 2 (maint + 2 IFU + 4 vigilance + 2 FSCs) $6,500 $4,500 $2,000
Year 3 (maint + 2 IFU + 4 vigilance + 2 FSCs) $6,500 $4,500 $2,000
3-Year Total $29,000 $17,100 $6,000
Year 1 share of 3-year spend 55% 47% 33%

Under hourly, 55% of the 3-year EC REP cost lands in Year 1 — exactly when the manufacturer is also paying the Notified Body. Flat fee frees ~$14,000 of Year 1 working capital for clinical investigations, Common Specifications testing, or commercial preparation.

Scenario C: 5-Device-Group Portfolio (MDR/IVDR Mix)

5 Basic UDI-DIs across MDR and IVDR (e.g., 3 Class IIa MDR + 1 IVDR Class B reagent + 1 IVDR Class C molecular diagnostic).

Cost Bucket Hourly Billing Setup + Annual Flat Fee (Pure Global, 5 groups)
Year 1 total $40,000–$60,000 $24,000–$38,000 $4,000
Year 2 $14,000–$24,000 $11,000–$18,000 $4,000
Year 3 $14,000–$24,000 $11,000–$18,000 $4,000
3-Year Total $68,000–$108,000 $46,000–$74,000 $12,000

The flat-fee tier discount (each additional group is $500 incremental, not multiplicative) compounds. A 5-group portfolio at Pure Global's published rates costs less than a single Class IIb device under hourly for one year — $800/group/year at the 5-group tier versus $2,800–$4,800/group/year typical at mid-tier providers.

Recommended Reading
Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
ANVISA Reimbursement & Market Access2026-04-24 · 34 min read

What "All-Inclusive" Actually Means: Scope Checklist

When EU AR proposals all claim to "include everything," the differences are in the fine print:

Service Item Hourly (typical) Setup + Annual (typical) Flat Fee — Pure Global
Article 11 mandate (per device group) hourly one-time setup fee included (per device group; tier table above)
EC REP/EU REP labeling symbol authorization included included included
EUDAMED Actor Module registration / SRN issuance hourly $300–$700 separate included
EUDAMED routine UDI/Device Module submissions for contracted groups hourly sometimes per-device included
EUDAMED bulk Device-module backfill for legacy portfolios hourly hourly separate — $200/hour ad-hoc
Article 11(3)(a) document review (routine) hourly (8–40 hrs) sometimes capped, sometimes hourly above included
Notified Body TDA review support beyond Article 11(3)(a) hourly hourly separate — $200/hour ad-hoc
Free Sale Certificate (FSC) request handling hourly + Member State fee $200–$2,200 each + fee included (handling); Member State fee passed through at cost
Vigilance forwarding to Competent Authorities under Article 11(3)(g) hourly hourly above scope or per event inherent to EC REP role — included (forwarding only; incident analysis is manufacturer's responsibility)
Competent Authority correspondence under Article 11(3)(d)–(f) hourly hourly above scope inherent to EC REP role — included
Mandate amendment for SKU additions inside a contracted device group hourly $150–$400 each included
Mandate amendment for adding a NEW device group (new Basic UDI-DI) hourly $150–$400 each + new annual moves to next tier (+$500–$1,000/year)
EC REP's own PRRC (Article 15(6) on the EC REP firm) "we have one" (assumed) "we have one" (assumed) included — required of any compliant EC REP
Manufacturer's PRRC under Article 15 (separate role on the manufacturer) not in EC REP scope not in EC REP scope not included — manufacturer's own obligation
Importer/distributor onboarding letters hourly per-letter included where inherent to mandate; otherwise ad-hoc
24-language IFU translations (Annex I Chapter III) not in EC REP scope not in EC REP scope not included
Classification / Regulatory Pathway / Gap Analysis hourly hourly separate consulting menu ($2,000–$5,000 each)
CER / PER writing hourly hourly separate consulting menu ($10,000–$30,000)
Technical Documentation writing hourly hourly separate consulting menu ($8,000–$15,000)
Notified Body audit attendance hourly hourly hourly ad-hoc ($200/hour)
EUDAMED government registration free free free (no Member State fee)
Notified Body application / TDA / surveillance fees passed through passed through passed through at cost (no markup)

The scope items that quietly drive Year-2-and-beyond overruns are: Article 11(3)(a) review depth, FSC volume, EUDAMED corrections, and vigilance triage. They typically account for 35–60% of post-Year-1 spend. Whether they are inside or outside the flat fee is the single biggest line in any comparison.

What 2026 EU Regulatory Churn Costs Under Each Pricing Model

The EU regulatory environment between 2022 and 2026 has generated more EC REP-billable events than at any point since the MDR went into application in May 2021. Each rule change forces Basic UDI-DI updates, EUDAMED data refreshes, mandate amendments, IFU updates, or vigilance pipeline adjustments. Under hourly or setup-plus-annual, every event is billable. Under flat fee, none is.

EC REP-Billable Events from 2022–2026 EU Rules

Regulation / Guidance Effective Modification Type Triggered Typical EC REP Events per Device
Regulation (EU) 2023/607 (MDR transitional extension) March 2023 Re-paperwork of legacy device declarations, EUDAMED legacy registration 1–2 events
Regulation (EU) 2024/1860 (IVDR transitional extension + EUDAMED phasing) July 2024 IVDR legacy device EUDAMED registration; Class D 12/2027, C 12/2028, B/A-sterile 12/2029 deadline alignment 1–3 events
Commission Decision (EU) 2025/2371 (EUDAMED 4-module functional declaration) Nov 2025 Six-month transition triggering 28 May 2026 mandatory go-live 1 mandatory event per actor
MDCG 2022-16 (EC REP PRRC distinctness) 2022 Mandate language update to confirm separate PRRC 1 amendment per mandate
MDCG 2023-3 / MDCG 2024 series (vigilance reporting clarifications) 2023–2025 Vigilance SOP updates flowing through to EC REP procedures 1–2 events
Common Specifications under MDR Article 9 (issued 2022–2025) Ongoing Class-specific testing/labeling compliance updates 1–2 IFU/labeling refreshes
EU AI Act, Regulation (EU) 2024/1689 Phased 2025–2027 High-risk AI device additional documentation in EUDAMED-adjacent records 1–2 events for AI-enabled devices
Cyber Resilience Act + NIS2 2024–2027 Cybersecurity documentation flowing into Article 11(3)(a) review scope 1–2 events for connected devices
MDR/IVDR Simplification Proposal COM(2025) 1023 Pending 2026 Anticipated SME fee reductions, possible reclassification adjustments 0–1 event (contingent on adoption)

Aggregated, a typical Class IIa MDR device on the EU market has triggered 4–7 cumulative EC REP events since 2022. Class IIb/III devices, with broader scope under Common Specifications and the AI Act, are closer to 6–10 events. IVDR Class C/D devices subject to the 2024/1860 transitional alignment have generated 3–6 events in the 2024–2026 window alone.

What That Event Volume Costs You

Pricing Model Per-Event Cost 4-Year (Class IIa, 6 events) 4-Year (Class IIb, 10 events)
Hourly billing $870–$1,740 $5,200–$10,400 $8,700–$17,400
Setup + annual $150–$2,200 $900–$13,200 $1,500–$22,000
Pure Global flat fee included $0 $0

Under hourly or setup-plus-annual, EU regulatory churn becomes a hidden tax that scales with how active Brussels is — not with how active you are.

What the EU Has Queued for 2026–2028

  • EUDAMED mandatory go-live, 28 May 2026. Four modules (Actor, UDI/Device, Notified Bodies and Certificates, Market Surveillance) become mandatory under Commission Decision (EU) 2025/2371. Legacy devices must register by 28 November 2026. The Vigilance/PMS module follows ~Q1 2027; the Clinical Investigations module is later.
  • IVDR Regulation (EU) 2024/1860 transitional cliffs: 31 December 2027 (Class D), 31 December 2028 (Class C), 31 December 2029 (Class B and Class A sterile). Each cliff drives mandate updates and EUDAMED state changes.
  • EU AI Act applicability to AI-enabled medical devices, phased through 2027.
  • Cyber Resilience Act + NIS2 for connected devices — cybersecurity documentation flows into Article 11(3)(a) scope.
  • MDR/IVDR Simplification Proposal COM(2025) 1023 — SME fee reductions in inter-institutional negotiation.
  • Common Specifications expansion under MDR Article 9 for nanomaterials, Annex XVI products, and software accessories through 2027.

A reasonable 2026–2028 forecast for an existing Class IIb MDR device is 3–5 additional EC REP events. At hourly rates: another $2,600–$8,700 per device. Under flat fee: $0. For a 5-device-group portfolio, the difference between "events included" and "events billable" over 2026–2028 is $15,000–$50,000 in net EU P&L impact.

When Flat Fee Wins, and When It Does Not

Flat fee usually wins when:

  • You expect to keep the device on the EU market for ≥3 years.
  • You have ≥2 Basic UDI-DIs (tier discounts compound).
  • Your devices are commercially active — ongoing EUDAMED updates, mandate amendments, FSC requests, vigilance pipeline.
  • You pursue export-market registrations using EU CE certificates (Brazil, MENA, ASEAN, LatAm), driving FSC volume.
  • You are capital-constrained in Year 1 and want to smooth cash outflow.

Hourly billing might still win when:

  • You are doing a one-time MDR feasibility or pre-classification opinion with no CE certificate yet.
  • You have a single Class I (non-sterile, non-measuring, non-reusable-surgical) self-certified device.
  • You need ad-hoc strategic counsel outside an existing EC REP relationship.

Setup-fee-plus-annual is rarely optimal on TCO grounds. It lands between hourly and flat fee on cost while preserving the Year 1 front-loading problem and the unbounded modification risk of itemized billing.

Recommended Reading
Colombia Medical Device Registration Cost 2026: INVIMA Representative Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
Regulatory Reimbursement & Market Access2026-04-24 · 42 min read

Government Fees: A Quick Reference

EU regulatory fees are unusually low at the headline level — the EU funds most infrastructure through Notified Body fees rather than direct government charges:

Filing EU/Member State Fee Approximate USD
EUDAMED Actor / UDI / NB modules €0 $0
Free Sale Certificate (typical Member State) €50–€600 $55–$650
Notified Body application fee €1,540 average $1,650
Notified Body TDA day rate €317–€450/day $345–$485/day
Notified Body annual surveillance fee €1,000–€10,584 $1,090–$11,500
Member State CA registration sub-charge €0–€800 $0–$870

For complete CE marking cost detail see How Much Does CE Marking Cost for Medical Devices?. For EUDAMED procedural detail see EUDAMED Registration: Complete Guide.

8 Questions to Ask Any EC REP Before You Sign

This checklist works regardless of which EU AR you are evaluating. Demand explicit, written answers before signing — not verbal assurances during the sales call.

  1. Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (Eurozone HICP? uncapped? at provider discretion?).
  2. What does Article 11(3)(a) document review actually consist of? Is it a 30-minute checklist or a 40-hour audit? How many hours are inside the annual fee, and at what hourly rate is overage billed?
  3. How many EUDAMED data submissions are included per year? Per Basic UDI-DI? Per UDI-DI? Are mandate amendments treated as new EUDAMED events?
  4. What is the per-hour rate for out-of-scope work? Some firms advertise low base fees and charge $400+/hour for anything outside scope. Get the T1/T2/T3 rate card in writing.
  5. Who pays if a Competent Authority issues a query? Under hourly, you do. Under flat fee, the EC REP should. Confirm in writing whether routine Article 11(3)(d)–(g) activities are flat-fee or above-scope.
  6. What are the termination terms? Pure Global publishes 50% payoff of remaining contract value. Many competitors require 100% payoff plus 6–12 months notice. This matters more than the headline price.
  7. Does the EC REP have its own PRRC, distinct from the manufacturer's PRRC, per MDCG 2022-16? Confirm the PRRC's name, qualifications, and that they are an employee or under continuous service contract — not a generic "PRRC pool."
  8. Will the EC REP provide a transfer letter and Article 12 cooperation at no cost if you decide to leave? Some firms hold the EUDAMED SRN linkage hostage during transitions. Get the transfer-out commitment, including the Article 12 tripartite agreement cooperation language, in writing before signing.

If an EC REP refuses to answer any of these in writing, that is the answer to the question.

EC REP Switching Playbook: How to Leave Without Getting Trapped

The single most expensive mistake in EU AR selection is signing a contract you cannot exit affordably. Many non-EU manufacturers discover, 18 months in, that their EC REP is mediocre but switching costs more than staying. This section is the operational playbook competitors avoid publishing.

The MDR Article 12 Change of Authorized Representative Procedure

MDR Article 12 (and the parallel IVDR Article 12) explicitly governs change of EU AR. A tripartite agreement is required:

Step Who Performs Typical Duration Notes
1. Manufacturer drafts new mandate with incoming EC REP Manufacturer + new EC REP 2–4 weeks Should cover all device groups; PRRC named
2. Tripartite Article 12 agreement signed (manufacturer + outgoing + incoming) All three parties 2–8 weeks This is the choke point. Outgoing EC REP cooperation pace varies wildly.
3. New EC REP's EUDAMED Actor record updated to link to manufacturer's devices New EC REP + Competent Authority 2–6 weeks Requires Competent Authority validation
4. Outgoing EC REP de-links and updates EUDAMED Actor data Outgoing EC REP 1–4 weeks Mostly mechanical
5. Notified Body and Competent Authorities notified New EC REP 1–2 weeks Particularly important if active CE certificates exist
6. Labeling and packaging updated to reflect new EC REP address Manufacturer Can run concurrent Use-up periods often allowed
Total realistic timeline 8–20 weeks Faster if outgoing EC REP cooperates

The bottleneck is almost always step 2. Article 12(3) requires the outgoing EC REP to set out the date of termination of its mandate in agreement with the incoming representative. An EC REP that wants to retain you can effectively delay your departure by stalling on the tripartite agreement signature.

Contract Termination Clauses: How They Actually Compare

The termination clause buried in your EC REP agreement is often more economically consequential than the headline annual fee. Common terms in the market:

Termination Term Typical Industry Practice Pure Global Published Term
Notice period required 6–12 months None — termination effective on contract anniversary
Payoff of remaining contract value on early exit 100% of remaining contract 50% payoff of remaining contract
Article 12 tripartite signature commitment "Reasonable cooperation" (undefined) Standard contract term
Separate "transfer fee" charged at exit $1,000–$5,000 typical None
Right to withhold EUDAMED de-linking Sometimes asserted via "reasonable time" Explicitly bounded
Labeling change-out grace period 30–90 days (varies) Negotiable in mandate

If you sign a typical industry EC REP contract today that requires 12 months notice plus 100% payoff of remaining term, the effective cost of switching mid-contract on a $4,000/year deal is $4,000 (notice fees) + $8,000 (remaining 2-year payoff) + $2,500 (transfer fee) + $3,000 (labeling rework) = $17,500 before you pay the new EC REP a cent. That is more than 5 years of flat-fee under Pure Global's published rate for a single device group.

The Distributor-as-EC-REP Lock-In Trap

The most common trap for first-time EU entrants: letting the EU distributor double as the EC REP. Up front this looks efficient. The economic reality is harsher and increasingly conflicts with MDR/IVDR Article 11(7) on conflicts of interest.

If your distributor or importer also holds the EC REP mandate:

  • Switching distributors becomes a regulatory event. You cannot terminate the distributor without simultaneously running an Article 12 Change of AR — adding 8–20 weeks and giving the outgoing distributor leverage over both relationships.
  • Article 11(7) conflict of interest. Article 13/14 importer/distributor obligations can collide with Article 11(3)(h) (terminate if manufacturer is non-compliant). Competent Authorities and Notified Bodies increasingly flag this during audits.
  • The "free EC REP" is priced into the distributor margin. Industry practice in the EU is 8–25% commercial markup. For a €5M EU business, that is €400,000–€1.25M/year of implicit EC REP cost.
  • Article 16 fall-through risk. A distributor that modifies packaging, translates IFUs, or rebrands can be deemed a manufacturer under Article 16, at which point the EC REP mandate becomes legally fragile.

The right structure: an independent EC REP holds the Article 11 mandate, with importers/distributors operating under Article 13/14 separately. You pay $2,000–$4,000/year for the EC REP and recapture the 8–25% distributor margin.

Clean Switching: 7-Step Sequencing

  1. Sign the new EC REP first, conditional on successful Article 12 transfer and EUDAMED Actor relinking.
  2. Draft fresh mandates with full device-group scope including Basic UDI-DIs before notifying the outgoing EC REP.
  3. Time the notice letter 30–60 days before contract anniversary to minimize early-termination cost.
  4. Cite specific MDR Article 12 cooperation obligations in your termination letter — many EC REPs cooperate when the regulatory citation is explicit.
  5. File the EUDAMED Actor relinkage the day after the tripartite is signed — do not wait for batch processing.
  6. Coordinate Notified Body notification — the certificate file must reflect the new EC REP for ongoing surveillance.
  7. Plan labeling change-out — most Competent Authorities accept 12–24 month use-up periods for existing stock.

A well-executed switch costs $3,000–$8,000 and 60–140 days. A poorly executed switch costs a year of EU market access. The termination clause is the upstream variable that determines which.

Recommended Reading
Clinical Equivalence Assessment Under EU MDR: Technical, Biological, and Clinical Equivalence
Clinical Evidence EU MDR / IVDR2026-04-24 · 12 min read

Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes

We modeled the same scope — single Basic UDI-DI, MDR Class IIa, 3-year EC REP relationship, all standard Article 11 inclusions, modest FSC and EUDAMED activity — under three pricing structures: Pure Global (rates verified on its public pricing page), plus two composite industry quotes built from typical RFP responses across the major EU AR providers (Obelis, MedPass International, Donawa Lifescience, Emergo by UL, Casus Consulting, Freyr, Veranex, MedNet, MedEnvoy). Composite columns use the midpoint of each range. Competitor firms are not named individually because, unlike Pure Global, they do not publish prices.

Same Scope, Three Models, 3-Year Total

Scope baseline: 1 Basic UDI-DI, MDR Class IIa, foreign manufacturer, 3-year contract, 4 EUDAMED data submissions/year (UDI-DI variants + cert linkage), 2 mandate amendments/year, 2 FSCs/year for export-market registrations, 4 vigilance forwards/year, 1 PMCF-driven IFU revision/year.

Line Item Pure Global (Flat Fee) Composite Hourly Quote Composite Setup+Annual Quote
Year 1 — mandate + Actor + SRN $2,000 (annual fee) $5,200 (~18 hrs × $290 blended) $3,800 ($1,000 setup + $500 SRN + $2,300 annual)
Year 1 — Article 11(3)(a) doc review included $2,300 (8 hrs T2) $1,200 (sometimes capped)
Year 1 — EUDAMED submissions (4) included $1,400 (5 hrs T3 + 2 hrs T2) $400–$1,200
Year 1 — 2 FSCs included $1,200 (4 hrs T3 + Member State fee) $600–$2,400 (per-FSC fees)
Year 1 — 2 mandate amendments included $700 (3 hrs blended) $300–$800
Year 1 — 4 vigilance forwards included $1,200 (4 hrs T2) $400–$1,600
Year 1 — 1 IFU revision included $580 (2 hrs T2) $300–$800
Year 1 total $2,000 $12,580 $7,000–$11,800
Year 2 — annual maintenance $2,000 $4,200 (15 hrs blended) $2,300–$3,200 base
Year 2 — 4 EUDAMED + 2 FSCs + 2 amendments + 4 vigilance + 1 IFU included $5,000 $2,000–$5,800
Year 3 — annual maintenance $2,000 $4,200 $2,300–$3,200
Year 3 — 4 EUDAMED + 2 FSCs + 2 amendments + 4 vigilance + 1 IFU included $5,000 $2,000–$5,800
3-Year Total $6,000 $30,980 $15,600–$29,800

(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical EU AR RFP responses observed by MedDeviceGuide; individual firm numbers vary.)

Key Takeaways from the Comparison

  • Pure Global is 5.2x cheaper than composite hourly over 3 years, and 2.6x–5.0x cheaper than composite setup-plus-annual.
  • Year 2 and Year 3 cost gaps widen further with above-average vigilance or FSC volume — the realistic case for most active devices given 2026 churn.
  • Setup-plus-annual has the widest bracket because providers vary enormously on whether EUDAMED submissions and FSCs are inside the annual fee. Read every "included" claim line by line.
  • Flat fee is insulated from invoice variance. The only variable is how many device groups — everything else is fixed.

Why Composite Instead of Named Competitors

No other major EU AR provider publishes complete prices, naming a firm with a specific number invites NDA disputes, and every quote varies by negotiation. The point of this analysis is the structural difference between pricing models, not which specific competitor is best. To get firm-specific pricing, issue your own RFP using the template below.

EC REP RFP Template Copy and Paste

Most EU AR RFPs come back from competing firms in three different formats with three different scope inclusion lists, making side-by-side comparison nearly impossible. Use the template below to force every responding firm into the same structure. Copy, paste, fill in the blanks, send.


Subject: Request for Proposal — EU Authorized Representative (EC REP) Services for [Manufacturer Name]

Dear [Provider],

[Manufacturer Name] is evaluating EU Authorized Representative service providers for our medical device / IVD portfolio entering or maintaining presence in the EU/EEA market under MDR 2017/745 / IVDR 2017/746. We are issuing this RFP to [N] firms and request a written proposal by [date].

Portfolio Scope

# Device Family Name Basic UDI-DI Issued? Regulation (MDR / IVDR) Class Currently CE-marked? # of UDI-DIs in Family
1 [Device A] [Yes/No] [MDR / IVDR] [I / Is/Im/Ir / IIa / IIb / III or A / B / C / D] [Yes/No] [N]
2 [Device B]

Contract Term: We anticipate a [3-year / 5-year] EC REP relationship. PRRC requirement: Confirm permanent and continuous PRRC access per MDR/IVDR Article 15(6), with PRRC distinct from manufacturer's PRRC per MDCG 2022-16.

Required Pricing Format

Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the base fee or billed separately, and if separately, on what unit basis.

Service Item Year 1 Cost Year 2 Cost Year 3 Cost Inclusion (Y/N) Per-Unit Rate if Separate
Article 11 mandate per device group
EUDAMED Actor Module / SRN administration
EUDAMED UDI/Device Module submissions — please state limit
Article 11(3)(a) document review — please state included hours
Free Sale Certificate requests — please state per-FSC fee and Member State pass-through
Mandate amendments — please state limit
Competent Authority correspondence
Vigilance forwarding (incidents, FSCAs)
PRRC consultations
Out-of-scope hourly rate (T1 / T2 / T3)
Notified Body TDA review support beyond Article 11(3)(a)
Notified Body audit attendance

Required Disclosures

  1. Annual fee escalation — fixed, HICP-linked, or uncapped?
  2. Notice period for non-renewal.
  3. Early termination payoff as % of remaining contract value.
  4. Article 12 tripartite cooperation commitment — committed days from request.
  5. Separate "transfer fee" charged at exit — yes/no, amount.
  6. EUDAMED Actor de-linking timeline at exit — committed days.
  7. Member State of EC REP establishment, PRRC name and qualifications.
  8. Whether you also operate as importer/distributor for our competitors (Article 11(7)).
  9. ISO 13485 certification of EC REP operations.
  10. 2–3 manufacturer references for 2025–2026 EUDAMED Actor or Article 12 transfers.

Evaluation Criteria: (1) total 3-year cost, (2) inclusion completeness, (3) termination flexibility, (4) PRRC qualifications, (5) responsiveness, (6) EUDAMED track record.

Please respond by [date] to [contact email].

Best regards,

[Your Name]

[Your Title], [Manufacturer Name]


This template forces every EC REP to price the same scope. The line items where firms diverge most — Article 11(3)(a) review depth, EUDAMED submissions, FSCs, vigilance, termination — are exactly what the template makes them disclose explicitly.

Frequently Asked Questions

Is an EU Authorized Representative the same as an EU distributor or importer?

No. The EC REP holds the Article 11 mandate. Importer (Article 13) and distributor (Article 14) have separate economic-operator obligations and register independently in EUDAMED. The same legal entity can play multiple roles, but combining EC REP with importer/distributor creates conflict-of-interest risk under Article 11(7).

Can I use one EC REP for all 27 EU Member States plus Iceland, Norway, and Liechtenstein?

Yes. Article 11 requires a single EC REP for the entire EU plus the EEA states Iceland, Norway, and Liechtenstein. Switzerland is not covered — Swiss market access requires a separate CH-REP under the Swiss Therapeutic Products Act.

Does Pure Global's $2,000/year flat fee really cover an MDR Class III implantable?

Yes — the EC REP mandate scope under Article 11 is statutorily the same regardless of class. The $2,000 fee covers one device group, MD or IVD, all classes. What is not covered is Notified Body conformity assessment, CER/PER writing, or technical documentation compilation — those are separately quoted on the consulting menu and can run $20,000–$80,000+ for Class III / IVDR Class D work.

How does the "device group" tier work if I have 200 SKUs?

The tier counter is Basic UDI-DIs, not SKUs. 200 SKUs sharing 4 Basic UDI-DIs = 4 device groups = $3,500/year. This is structurally cheaper than the per-device pricing most setup-plus-annual providers use, where the 201st SKU adds another €100–€300/year.

What about IVDR transitional devices under Regulation (EU) 2024/1860?

The EC REP mandate applies whether the device is on a fresh IVDR certificate or under the transitional provisions (Class D 12/2027, Class C 12/2028, Class B and Class A sterile 12/2029). Each cliff triggers a small mandate amendment and EUDAMED refresh — both inside Pure Global's flat fee.

Will the China-based experts model affect my Article 11 PRRC compliance?

No. The EC REP mandate, the SRN, and the PRRC must be EU-resident regardless. The China-based experts model applies only to the separate consulting menu (classification, gap analysis, CER/PER, technical documentation) — not the EC REP function.

Can I switch EC REPs mid-CE-certificate cycle?

Yes. Article 12 explicitly permits change of EC REP subject to the tripartite agreement and Notified Body notification. The CE certificate is not voided — it is amended. Plan 8–20 weeks for full Article 12 process plus EUDAMED relinkage and labeling change-out.

How does EU EC REP cost compare to other major markets?

Pure Global's flat-fee EC REP ($2,000–$4,000/year for 1–5 device groups) is cheaper than Japan DMAH ($15,000–$50,000/year) and Australia Sponsor ($3,000–$8,000/year), comparable to UK RP ($1,500–$3,500/year) and Brazil BRH ($2,000–$6,000/year). See Medical Device Registration Cost by Country: 2026 Global Comparison.

Do I need the EC REP's address on every label?

Yes. MDR/IVDR Annex I Chapter III requires the EC REP's name and address on label, packaging, or IFU, preceded by the EC REP / EU REP symbol per ISO 15223-1. Switching triggers a labeling change-out, typically with a 12–24 month use-up period.

Bottom Line

EUDAMED registration is free. Notified Body fees are independently published. The line item that wrecks EU market-access budgets is the EC REP service fee — specifically the cash-flow shape and which "all-inclusive" claims survive contact with reality. Hourly front-loads 55–60% of 3-year cost into Year 1; setup-plus-annual front-loads 45–50%; flat fee flattens it to 33% per year — the only model that aligns with how MedTech revenue actually scales. The numbers in this guide are 2026 benchmarks. The pricing-model questions are timeless. Ask them before you sign.

Related Articles

Reimbursement & Market AccessCommercialization

Australia Medical Device Registration Cost 2026: Australian Sponsor Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How much does it cost to register a medical device in Australia in 2026? A buyer-side breakdown of Australian Sponsor service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for ARTG inclusion across Class I through Class III/AIMD devices.

2026-04-24·41 min read
RegulatoryCommercialization

Bangladesh DGDA Medical Device Registration Guide: Classification, Import Permits, and Local Representative Requirements

Complete guide to registering medical devices in Bangladesh through the Directorate General of Drug Administration (DGDA) — four-tier risk classification (A–D) aligned with ASEAN MDD, two-step Recipe Approval and Final Registration process, reference country Free Sale Certificate requirements, local authorized representative obligations, import licensing and indent approval workflow, Maximum Retail Price (MRP), Bengali labeling, ISO 13485 QMS expectations, Drug and Cosmetics Act 2023, fees, timelines, and South Asia market strategy.

2026-04-24·13 min read
Risk ManagementRegulatory

Benefit-Risk Analysis for Medical Devices: FDA, EU MDR, and ISO 14971 Decision Framework

Complete guide to benefit-risk analysis for medical devices — ISO 14971:2019 residual risk evaluation, EU MDR AFAP requirements, FDA benefit-risk factors for PMA/De Novo/510(k), MDCG guidance, practical examples, and documentation best practices.

2026-04-24·12 min read